Recruiting A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer NCT07644559 Conditions Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more Locations START- Los Angeles — Los Angeles, California, United States Valkyrie Clinical Trials — Los Angeles, California, United States Moffitt Cancer Center — Tampa, Florida, United States Johns Hopkins University — Baltimore, Maryland, United States View all 19 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors NCT07020221 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more Locations Cedars-Sinai Medical Center — Los Angeles, California, United States Johns Hopkins University — Baltimore, Maryland, United States Massachusetts General Hospital — Boston, Massachusetts, United States University of Michigan — Ann Arbor, Michigan, United States View all 14 locations View more locations Show fewer locations Loading locations... View Trial Details
